Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00BVJ
|
||||
Former ID |
DIB006728
|
||||
Drug Name |
NHS-IL 12
|
||||
Synonyms |
NHS-IL12
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [523590] | ||
Company |
Emd serono; national cancer institute
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-12 ligand | Target Info | Modulator | [532724] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
Toll-like receptor signaling pathway | |||||
RIG-I-like receptor signaling pathway | |||||
Jak-STAT signaling pathway | |||||
Type I diabetes mellitus | |||||
Pertussis | |||||
Legionellosis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
African trypanosomiasis | |||||
Malaria | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Measles | |||||
Influenza A | |||||
Herpes simplex infection | |||||
Inflammatory bowel disease (IBD) | |||||
Allograft rejection | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.